Results 231 to 240 of about 1,093,896 (249)

Role of Janus Kinase Inhibitors in Therapy of Psoriasis

Journal of Clinical Medicine, 2021
Janus kinases inhibitors are molecules that target Janus kinases—signal transducers and activators of transcription (JAK/STAT). They inhibit this intracellular signal pathway, blocking the gene transcription of crucial proinflammatory cytokines that play
Andrzej Pawlik, Sylwia Słuczanowska-Głąbowska, Kamila Szumilas   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Potential Use of Janus Kinase Inhibitors in the Treatment of Systemic Lupus Erythematosus

Journal of Inflammation Research, 2023
Jin-Ying Lin
exaly  

Oral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study

Journal of the American Academy of Dermatology, 2023

exaly  

Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis

Journal of Dermatological Treatment, 2022
Kevin Phan, Steven Phan
exaly  

Janus kinase inhibitors in dermatology: Part II. A comprehensive review

Journal of the American Academy of Dermatology, 2022
Henry W Lim, Linda F Stein Gold
exaly  

Janus kinase inhibitors in dermatology: Part I. A comprehensive review

Journal of the American Academy of Dermatology, 2022
Henry W Lim, Linda F Stein Gold
exaly  

Comparative efficacy and safety of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and network meta-analysis

Therapeutic Advances in Musculoskeletal Disease, 2021
Chenghua Weng, Leixi Xue, Zhichun Liu
exaly  

Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs)

Bioorganic and Medicinal Chemistry Letters, 2009
Herbert R Treutlein, Emmanuelle Fantino, Tracy L Nero   +2 more
exaly  

Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature

Journal of Dermatological Treatment, 2017
Alireza Firooz, Aniseh Samadi, Mansour Nassiri Kashani   +2 more
exaly  

Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases

Journal of Cellular Physiology, 2020
Zohreh Babaloo, Faroogh Marofi, Behzad Baradaran   +2 more
exaly